Olumide Adeleke Thomas, Aigbiremo Oboh Mary, Yetunde Olasinde, Agnes Akinlosotu Morenike, Naomi Oluwasanya Alarape, Victoria Adeleke Oludamola, Samson Timothy Kayode
Family Medicine Department, Bowen University, Iwo, Osun State, Nigeria.
Microbiology Department, Bowen University, Iwo, Osun State, Nigeria.
Child Care Health Dev. 2025 Jan;51(1):e70029. doi: 10.1111/cch.70029.
Malaria remains a major cause of preventable deaths among children worldwide, despite the availability of several interventions for controlling and eliminating the disease. The WHO recommended the first malaria vaccine, RTS, S/AS01 in October 2021 to immunize children in sub-Saharan Africa. In this study, we set out to evaluate the knowledge, awareness and acceptability of the malaria vaccine among mothers of under 5 in south-west Nigeria before the vaccine's rollout in Nigeria.
We employed a hospital-based cross-sectional study for this study. A pretested semistructured, interviewer-administered questionnaire was used to elicit information from the study participants. Data obtained were analysed using the Statistical Package for Social Sciences (SPSS version 20.0).
A total of 797 respondents participated in the study. Only 26.0% of the respondents were aware of the new vaccine. However, the majority (90.0%) were willing to accept the malaria vaccination and to pay for it (82.1%). The crude odds ratio reveals that the odds of awareness of the malaria vaccine were more than 5 times higher among those who have tertiary education (OR = 5.470, CI = 1.224-24.444) compared with those with primary education.
The level of awareness of the malarial vaccine is low among the caregivers of under 5 children living in south-western Nigeria. However, the willingness to accept the vaccine is high. Recruiting, training and retraining of healthcare providers and other stakeholders with the designated role of providing health education on malaria prevention and vaccines are key in ensuring the success of malaria vaccination.
尽管有多种控制和消除疟疾的干预措施，但疟疾仍然是全球儿童可预防死亡的主要原因。2021年10月，世界卫生组织推荐了第一种疟疾疫苗RTS,S/AS01，用于撒哈拉以南非洲地区的儿童免疫接种。在本研究中，我们旨在评估在尼日利亚西南部5岁以下儿童的母亲中，在疟疾疫苗在尼日利亚推出之前，她们对该疫苗的知识、认知度和可接受性。
我们采用了一项基于医院的横断面研究。使用经过预测试的半结构化、由访谈员管理的问卷从研究参与者那里获取信息。使用社会科学统计软件包（SPSS 20.0版）对获得的数据进行分析。
共有797名受访者参与了该研究。只有26.0%的受访者知道这种新疫苗。然而，大多数人（90.0%）愿意接受疟疾疫苗接种并为此付费（82.1%）。粗略比值比显示，受过高等教育的人对疟疾疫苗的知晓几率是受过小学教育的人的5倍多（OR = 5.470，CI = 1.224 - 24.444）。
在尼日利亚西南部生活的5岁以下儿童的照料者中，对疟疾疫苗的认知水平较低。然而，接受疫苗的意愿很高。招募、培训和再培训医疗保健提供者以及其他具有提供疟疾预防和疫苗健康教育指定角色的利益相关者，是确保疟疾疫苗接种成功的关键。
